Advertisement
HomeCollectionsEli Lilly
IN THE NEWS

Eli Lilly

FEATURED ARTICLES
BUSINESS
By Andrew Leckey and Andrew Leckey,Tribune Media Services | March 11, 1992
Q. I have owned shares of Eli Lilly for some time and have weathered the Prozac storm. What are your thoughts on this investment?A. You may have to weather further volatility, for there are still some clouds on the horizon.The Prozac anti-depressant agent remains the determining factor in how well Eli Lilly & Co. (around $75 a share, New York Stock Exchange) does or doesn't do, said Barbara Ryan, analyst with Prudential Securities.Competing drug company Pfizer Inc. has launched a similar product called Zoloft, which could have an impact on Prozac sales if it becomes popular.
ARTICLES BY DATE
BUSINESS
By Lorraine Mirabella, The Baltimore Sun | September 26, 2012
McCormick & Co. Inc. has appointed an Eli Lilly and Co. executive to its board of directors, the Hunt Valley spice and flavoring company said Wednesday. The appointment of Jacques Tapiero, a Lilly senior vice president and president of emerging markets, took effect Sept. 24. Tapiero has led Lilly's emerging markets unit since 2009, developing business strategy in China, Russia, Brazil, Mexico, South Korea and Turkey. He joined Lilly in 1983 and has had more than 25 years of international business experience with the Indianapolis-based pharmaceutical company.
Advertisement
BUSINESS
By BLOOMBERG NEWS | October 21, 1997
NEW YORK -- U.S. stocks rose for the first time in four days after AT&T Corp. and Eli Lilly & Co. reported earnings that topped expectations, easing concern that slowing profits will derail this year's rally.A rebound in computer-related issues such as Intel Corp. fueled the advance. Investors said last week's rout in those shares, triggered by concern about profits, was overdone.Microsoft Corp. and International Business Machines Corp., two of the industry's most-watched companies, reported third-quarter earnings that beat Wall Street estimates after the close of trading.
NEWS
By New York Times News Service | April 28, 2007
WASHINGTON -- The head of the Agency for International Development, Randall L. Tobias, resigned abruptly yesterday for what he said were "personal reasons," but an administration official said Tobias' name had come up in an investigation of a suspected Washington prostitution ring. Last night, ABC News said Tobias had confirmed on Thursday that he was a customer of an escort service. A woman from Vallejo, Calif., Deborah J. Palfrey, has pleaded not guilty to charges that she operated a call-girl service in Washington, and has threatened on her Web site to sell her client list to raise money for her defense.
NEWS
March 20, 2003
A quotation in an article in yesterday's Sun about the anti-psychotic drug Zyprexa was misleading. Marni Lemons, a spokeswoman for Eli Lilly and Co., says she was referring to press coverage of drug-safety concerns, not putting warnings on her company's product label, when she said it has "the potential to misinform patients and their caregivers."
BUSINESS
By NEW YORK TIMES NEWS SERVICE | January 1, 2005
An article in a medical journal today suggested that drugmaker Eli Lilly & Co. had long concealed evidence that its well-known antidepressant, Prozac, could cause violent and suicidal behavior. The accusations were made in the Jan. 1 issue of The British Medical Journal, which said it had turned over documents related to the allegations to the U.S. Food and Drug Administration. The FDA was reviewing the papers, which had been missing for more than 10 years, according to the Journal article, which said they were originally gathered during a lawsuit against Eli Lilly & Co. on behalf of victims of a gunman in Kentucky who reportedly had been taking Prozac for a month before going on a rampage.
BUSINESS
October 17, 2004
A weekly briefing on the economic calendar Monday Earnings reports: 3M, ETrade, Kraft Foods, Stanley Works, Texas Instruments Tuesday Housing starts and building permits for September. Consumer Price Index for September. Earnings reports: Altria, Ameritrade, Boise Cascade, Charles Schwab, Continental Airlines, DominoM-Fs Pizza, Ford Motor, Manpower, McDonaldM-Fs, Safeway, Sprint FON, US Bancorp, Wells Fargo, Electronic Arts, Motorola& Johnson Wednesday Earnings reports: AMR Corp.
BUSINESS
January 18, 1994
Sega to get Microsoft softwareThe Microsoft Corp. will reportedly supply portions of the basic software for controlling the new video game machine to be introduced late this year by Sega Enterprises.The agreement to contribute to an operating system for Sega could represent a big stride beyond personal computing for Microsoft.Crop Genetics plans swapCrop Genetics International said yesterday that it will seek to exchange shares of common stock for up to 1 million shares of its outstanding convertible preferred stock.
BUSINESS
November 4, 1994
Teleport seeks Baltimore marketTeleport Communications Group, a Staten Island, N.Y., company, has asked the state Public Service Commission for permission to provide local phone service for Baltimore-area businesses.Larry Bugden, vice president and general manager of TCG's Baltimore office, said the company seeks to offer businesses local telephone and telecommunications services beginning in the Baltimore area, then branch out through the state.Two other companies, MCI Communications and MFS Communications Co. Inc., of Omaha, Neb., also have applied with the PSC for authority to compete with Bell Atlantic Corp.
BUSINESS
January 19, 1994
Japan to accept foreign bidsUnder pressure from Washington, the Japanese government yesterday approved a plan to open bidding on its lucrative public works programs to foreign companies.It was not clear whether the changes would fully satisfy U.S. demands for greater access to Japan's construction market.The plan, which takes effect April 1, calls for competitive bidding on major public works projects by the central government that are worth at least $7.69 million, which would include about 20 percent of Japan's public works projects.
BUSINESS
By Bloomberg News | November 29, 2006
NEW YORK -- Pfizer Inc. will slash 2,200 U.S. sales jobs as the world's largest drugmaker reduces expenses to compensate for revenue lost to cheaper generic pharmaceuticals. The 20 percent cut in Pfizer's sales staff of 11,000 is an "initial step" growing out of a companywide review of operations announced in October, Pfizer said in a statement yesterday. Pfizer said it would outline additional steps in January. Members of the U.S. sales staff will be notified next month whether they are among those being fired, said Paul Fitzhenry, a Pfizer spokesman.
BUSINESS
By BLOOMBERG NEWS | January 17, 2006
SAN FRANCISCO -- GTx Inc. Chief Executive Officer Mitchell S. Steiner is seeking a partner for the company's first product, a prostate cancer drug, and there's one thing clearly at the top of his wish list: control. "I don't want to be Pfizer's little boy" or anybody's, Steiner said in a recent interview. "I want to be able to build name recognition for when product No. 2 reaches the market." He might get his wish. As big drugmakers, increasingly desperate for new products, race to buy rights to treatments invented by small biotechnology companies, it has become a seller's market, investors and company executives say. The competition is changing the kinds of deals being made and forcing companies to bid earlier in the testing of new treatments.
BUSINESS
By NEW YORK TIMES NEWS SERVICE | January 1, 2005
An article in a medical journal today suggested that drugmaker Eli Lilly & Co. had long concealed evidence that its well-known antidepressant, Prozac, could cause violent and suicidal behavior. The accusations were made in the Jan. 1 issue of The British Medical Journal, which said it had turned over documents related to the allegations to the U.S. Food and Drug Administration. The FDA was reviewing the papers, which had been missing for more than 10 years, according to the Journal article, which said they were originally gathered during a lawsuit against Eli Lilly & Co. on behalf of victims of a gunman in Kentucky who reportedly had been taking Prozac for a month before going on a rampage.
BUSINESS
October 17, 2004
A weekly briefing on the economic calendar Monday Earnings reports: 3M, ETrade, Kraft Foods, Stanley Works, Texas Instruments Tuesday Housing starts and building permits for September. Consumer Price Index for September. Earnings reports: Altria, Ameritrade, Boise Cascade, Charles Schwab, Continental Airlines, DominoM-Fs Pizza, Ford Motor, Manpower, McDonaldM-Fs, Safeway, Sprint FON, US Bancorp, Wells Fargo, Electronic Arts, Motorola& Johnson Wednesday Earnings reports: AMR Corp.
NEWS
March 20, 2003
A quotation in an article in yesterday's Sun about the anti-psychotic drug Zyprexa was misleading. Marni Lemons, a spokeswoman for Eli Lilly and Co., says she was referring to press coverage of drug-safety concerns, not putting warnings on her company's product label, when she said it has "the potential to misinform patients and their caregivers."
NEWS
By Nick Anderson and Nick Anderson,SPECIAL TO THE SUN | November 19, 2002
WASHINGTON - The Senate divided sharply yesterday on a Democratic proposal to strip a handful of special-interest provisions from the bill that would create a new homeland security agency. The Democratic amendment has prompted a heated debate over legal protections for vaccine makers and other businesses at a moment when Bush stands on the verge of achieving the most significant government reorganization since the start of the Cold War. At issue are seven provisions in the House-passed homeland security bill.
BUSINESS
October 14, 1994
Liberty Financial to buy ColonialLiberty Financial Cos. Inc. said yesterday that it has agreed to acquire the Colonial Group Inc. for about $310 million in cash and stock.Colonial is the nation's 29th largest mutual fund company, with $14 billion in assets under management for 800,000 investors.Liberty, with about $29 billion in assets under management, is a subsidiary of financial services conglomerate Liberty Mutual Group.Under the proposed deal, Colonial stockholders would have a choice of swapping each Colonial share for $40 in cash; one share of common stock in Liberty Financial Cos.; or 0.77 share of a newly issued preferred stock.
BUSINESS
By Lorraine Mirabella, The Baltimore Sun | September 26, 2012
McCormick & Co. Inc. has appointed an Eli Lilly and Co. executive to its board of directors, the Hunt Valley spice and flavoring company said Wednesday. The appointment of Jacques Tapiero, a Lilly senior vice president and president of emerging markets, took effect Sept. 24. Tapiero has led Lilly's emerging markets unit since 2009, developing business strategy in China, Russia, Brazil, Mexico, South Korea and Turkey. He joined Lilly in 1983 and has had more than 25 years of international business experience with the Indianapolis-based pharmaceutical company.
NEWS
By NEW YORK TIMES NEWS SERVICE | November 10, 2002
In the few months since a study of a widely used hormone regimen found that its risks outweighed its benefits, the prevailing view of menopause has undergone a momentous shift. For decades, women have been told that the symptoms of menopause - hot flashes and night sweats, as well as vaginal dryness that could make sex a painful ordeal and libido a distant memory - were burdens they should not have to bear. With hormone replacement therapy, they would feel as if the clock were turned back.
ENTERTAINMENT
By Linda Marsa and By Linda Marsa,LOS ANGELES TIMES | October 6, 2002
What's in a name? Plenty, if you ask Albert Cialis, a retired accountant in southern England. When he discovered that a new impotence drug from Eli Lilly & Co. shared his surname, he was mortified. If the drug became well-known, wouldn't being Mr. Cialis be the equivalent of having the name "Mr. Viagra"? "It's an unfortunate coincidence," said Nicole Hebert, a spokeswoman for Eli Lilly, which makes Cialis, a soon-to-be rival to the blockbuster drug Viagra. Lilly is considering Cialis' request to rename the drug, she said.
Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.